Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CASSAVA SCIENCES, INC.

(SAVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société CASSAVA SCIENCES, INC.
01/24Top Ideas in the Small Cap Biotech Space (LEXTF, ABBV, SAVA, SNDL, RETA, PAHC)
AQ
01/20Canadian Biotech Disruptor Lexston Life Sciences is unlocking the God Molecule (LEXTF, ..
AQ
01/06CASSAVA SCIENCES INC : Change in Directors or Principal Officers, Financial Statements and..
AQ
2021Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam..
GL
2021Cassava Sciences, Inc. - Science Journal Finds No Evidence to Support Claims of Data Ma..
AQ
2021Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Public..
GL
2021CASSAVA SCIENCES : Corporate Presentation – December 2021
PU
2021Top Ideas in the Small Cap Biotech Space (INMB, OTLC, DVAX, SAVA, ICPT, IMGN)
AQ
2021CORRECTING AND REPLACING CASSAVA SCI : Bragar Eagel & Squire, P.C. Is Investigating Cassav..
BU
2021CASSAVA SCIENCES : Corporate Presentation – November 2021
PU
2021Cassava Sciences Initiates a Second Phase 3 Study of Simufilam for the Treatment of Pat..
AQ
2021CASSAVA SCIENCES INC Management's Discussion and Analysis of Financial Condition and R..
AQ
2021Cassava Sciences Reports Third Quarter 2021 Financial Results - Form 8-K
PU
2021Cassava Sciences Reports Third Quarter 2021 Financial Results
AQ
2021CTAD 2021 Poster
PU
2021Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical P..
AQ
2021Thinking about buying stock in Cassava Sciences, Bitfarms, Big 5 Sporting Goods, Micros..
PR
2021Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical P..
GL
2021SHAREHOLDER ALERT : Robbins LLP Investigates Cassava Sciences, Inc. (SAVA) on Behalf of Sh..
BU
2021CASSAVA SCIENCES 24 HOUR DEADLINE AL : Former Louisiana Attorney General and Kahn Swick & ..
PR
2021CASSAVA SCIENCES 96 HOUR DEADLINE AL : Former Louisiana Attorney General and Kahn Swick & ..
BU
2021CASSAVA SCIENCES : Initiates a Phase 3 Efficacy Trial of Simufilam for the Treatment of Pa..
AQ
2021CASSAVA SCIENCES : Initiates a Phase 3 Efficacy Trial of Simufilam for the Treatment of Pa..
GL
2021CASSAVA SCIENCES : Announces Top-line Results of 12-month Interim Analysis from Open-label..
AQ
2021Cassava Sciences Announces Top-line Results of 12-month Interim Analysis from Open-labe..
GL
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassa..
PR
2021CASSAVA SCIENCES : HAGENS BERMAN Encourages Cassava Sciences (SAVA) Investors with Signifi..
PR
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassa..
PR
2021CASSAVA SCIENCES : to Present at H.C. Wainwright's 23rd Annual Global Investment Conferenc..
AQ
2021CASSAVA SCIENCES : to Present at H.C. Wainwright's 23rd Annual Global Investment Conferenc..
AQ
2021CASSAVA SCIENCES SHAREHOLDER ALERT B : Kahn Swick & Foti, LLC Reminds Investors With Losse..
BU
2021CASSAVA SCIENCES : Corporate Presentation – September 2021
PU
2021CASSAVA SCIENCES : Releases a Public Statement Regarding Recent Allegations
AQ
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassa..
PR
2021CASSAVA SCIENCES : Public Statement
PU
2021CASSAVA SCIENCES : Releases a Public Statement Regarding Recent Allegations
AQ
2021CASSAVA SCIENCES : HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, I..
PR
2021SHAREHOLDER ALERT : Robbins LLP Announces that Cassava Sciences, Inc. (SAVA) is Being Sued..
BU
2021CASSAVA SCIENCES : HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, I..
PR
2021CASSAVA SCIENCES : Releases Statement Regarding Plasma p-tau Analysis from a Previously Di..
AQ
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Continues Its Investiga..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Continues Investigation of Cassava Sciences, Inc. (SAVA..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Continues Investigation of Cassava Science..
BU
2021CASSAVA SCIENCES : Releases Statement Regarding Plasma p-tau Analysis from a Previously Di..
AQ
2021ONGOING INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Aga..
PR
2021CASSAVA SCIENCES ALERT : Bragar Eagel & Squire, P.C. Is Investigating Cassava Sciences on ..
BU
2021INVESTIGATION REMINDER : The Schall Law Firm Announces it is Investigating Claims Against ..
BU
2021EQUITY ALERT : ROSEN, A TOP RANKED LAW FIRM, Encourages Cassava Sciences, Inc. Investors w..
BU
2021CASSAVA SCIENCES : HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cassava Sciences, I..
PR
2021INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating Claims Against Cas..
BU
2021GLANCY PRONGAY & MURRAY LLP : a National Class Action Law Firm, Continues Investigation of..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Continues Investigation of Cassava Sciences, Inc. (SAVA..
BU
2021INVESTOR ALERT : Law Offices of Howard G. Smith Continues Investigation of Cassava Science..
BU
2021THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Cassava Sciences, Inc. (SAVA..
BU
2021GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
2021Cassava Sciences Responds to Allegations
GL
2021INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Cassava Science..
BU
2021CASSAVA SCIENCES : Announces Agreement with FDA on Special Protocol Assessments (SPA) for ..
AQ
2021CASSAVA SCIENCES : Corporate Presentation – August 2021
PU
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassa..
PR
2021CASSAVA SCIENCES : Management's Discussion and Analysis of Financial Condition and Results..
AQ
2021SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassa..
PR
2021CASSAVA SCIENCES : Baseline Overview Simufilam 9-Month Interim Analysis, First 50 Subjects..
PU
2021CASSAVA SCIENCES INC : Regulation FD Disclosure, Other Events, Financial Statements and Ex..
AQ
2021CASSAVA SCIENCES : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
2021CASSAVA SCIENCES : Reports Second Quarter 2021 Financial Results
AQ
2021Cassava Sciences Announces Conference Call for Second Quarter Financial Results
GL
2021CASSAVA SCIENCES : Thinking about buying stock in Bit Digital, Dolphin Entertainment, Arde..
PR
2021Cassava Sciences Announces Positive Cognition Data With Simufilam in Alzheimer's Diseas..
GL
2021Cassava Sciences Announces Positive Biomarker Data with Simufilam in Alzheimer's Diseas..
GL
2021Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase..
GL
2021CASSAVA SCIENCES : New Clinical Data for SavaDx to be Shared in a Poster Presentation and ..
AQ
2021CASSAVA SCIENCES : to Present New Clinical Dataset at 2021 Alzheimer's Association Interna..
AQ
2021CASSAVA SCIENCES : Corporate Presentation – July 2021
PU
2021CASSAVA SCIENCES : Selects Clinical Research Organization for Phase 3 Clinical Program in ..
AQ
1  2  3Next
Upcoming event on CASSAVA SCIENCES, INC.
03/30/22